CPhI China 2013 Increases Customer Content Services and Expands Thanks to a Double Digit Pharma Industry Growth Rate and a Burgeoning Generics Market
CPhI China 2013 Increases Customer Content Services and Expands Thanks to a Double Digit Pharma Industry Growth Rate and a Burgeoning Generics Market
AsiaNet 52934
AMSTERDAM, May 7/PRN=KYODO JBN/ --
Co-located events P-MEC/ICSE/BioPh/InnoPack/LABWorld are helping to build
improved partnerships and drive GMP standards across the region
CPhI announces that CPhI China [http://www.cphi-china.com ], an event
organised by UBM Live and UBM Sinoexpo, is returning to the Shanghai New
International Expo Center (25-27 June 2013, Shanghai) for the 13th consecutive
year - with an increased scale, more informative exhibition and regional
networking opportunities and a greater range of content services than it has
ever offered before. With a view to enhancing the customer experience and ROI
value, CPhI China has added mobile applications, high value conferences, a live
laboratory showcase and re-launched the show daily. Furthermore, the
2013 event has a strong focus on R&D with LABWorld, BioPharma and ICSE all
contained in one hall. China has increasingly become a focal point of the
pharmaceutical industry and is now the 3rd largest market in the world. Fuelled
by increasing healthcare demands within its own borders as well as by
international companies seeking manufacturing facilities, China's hunger for
foreign partnerships and pharmaceutical ingredients presents a great
opportunity for international and domestic suppliers and buyers.
CPhI China is back this year as the main event for the pharmaceutical
ingredients industry in the fast growing Chinese market. We expect to welcome
2,300 exhibitors, and 30,000 visitors from more than 100 countries, CPhI China
2013 is a unique one-stop platform to meet current partners, build new
relationships, evaluate pharmaceutical products and learn about the latest
industry trends.
Co-located events re-confirmed for the 2013 edition will be P-MEC China,
which covers machinery and equipment; ICSE China, for companies providing
outsourcing services in custom synthesis and clinical trials; BioPh China, a
dedicated platform for biopharmaceuticals; and InnoPack, focussed on bringing
global packaging solutions to the Chinese pharma companies. Additionally,
following huge demand in 2012, this year will also see a significant expansion
of co-located event, LABWorld China - which will focus on innovation and new
developments, providing a forum for increased education and networking for
businesses in the laboratory, analytical and biotech equipment sector.
The number of exhibitors already registered has seen a tremendous upsurge
thanks to increased Chinese manufacturing opportunities and huge growth in
China's generics sector. This rapid development, coupled with the evolving
regulatory landscape is attracting both domestic and international investors to
the Chinese market.
CPhI China 2013 brings great expectations and is a must attend event for
anyone interested in breaking into China's pharmaceuticals market and
establishing Chinese partners.
"In 2012, the size of the Chinese pharmaceutical market reached 926.1
billion RMB, and is expected to expand at an annual rate of 12% from 2013 to
2020," announced Nik Rudge, Managing Director at UBM Live. "Today, leading
Chinese CROs and pharmaceutical companies are able to offer high quality,
cost-effective services on a global scale with growth rates forecast to far
outpace the rest of the industry. The increasing ability of Chinese companies
to meet international standards in drug quality and safety, coupled with strong
growth in the local market, makes this is a must attend event for any
pharmaceutical
company in 2013 - whether Chinese, regional or international in focus."
Attendance to the events is free for qualified pharmaceutical professionals
Event information:
CPhI China
25-27 June 2013
The Shanghai New International Expo Center
Notes for Editors
About CPhI
CPhI drives growth and innovation at every step of the global
pharmaceutical supply chain from drug discovery to finished dosage. Through
exhibitions, conferences and online communities, CPhI brings together more than
100,000 pharmaceutical professionals each year to network, identify business
opportunities and expand the global market. The flagship event, CPhI Worldwide
is held in Europe, with additional events in China, India, Japan, Southeast
Asia, Russia and South America co-located with ICSE for contract services, P-MEC
for equipment, InnoPack for packaging and BioPh for biopharma. CPhI provides an
online buyer & supplier directory at CPhI-Online.com and hosts a global
community with news and analysis at PharmaEvolution.com, produced by UBM Live
and partners.
For more information visit: http://www.cphi.com
About UBM Live
UBM Live connects people and creates opportunities for companies across five
continents to develop new business, meet customers, launch new products,
promote their brands, and expand their market. Through premier brands such as
TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete
Show, and many others, UBM Live exhibitions, conferences, awards programs,
publications, Websites, and training and certification programs are an integral
part of the marketing plans of companies across more than 20 industry sectors.
For media enquiries, please contact:
Alex Heeley or Tristan Jervis
De Facto Communications
T: +44-207-203-6745/6740
E: a.heeley@defacto.com t.jervis@defacto.com
SOURCE: UBM Live
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。